<DOC>
	<DOCNO>NCT01682148</DOCNO>
	<brief_summary>The aim study compare Dysport treatment result current clinical practice injection technique high-concentration dilution neuromuscular junction target injection technique low-concentration dilution elbow joint assess Modified Ashworth Scale 4 week post treatment . The hypothesis one high volume injection centrally locate area/band NMJ zone effective technique use today current medical practice .</brief_summary>
	<brief_title>Neuro Muscular Junction Study</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<criteria>Provision write informed consent prior study related procedure Subjects male female , age 18 old Upper limb spasticity post stroke traumatic brain injury Spasticity position pattern type 1 , 3 4 Elbow flexor muscle spasticity MAS 2 3 At least 2 consecutive previous treatment cycle BoNTA current diagnosis The late treatment cycle demonstrate good treatment efficacy Dysport dose administer consider adequate accord Investigator judgement Need treatment modality previous treatment cycle , Last BoNTA treatment 1224 week ago Poor response BoNTA treatment , accord Investigator Need Dysport dose &gt; 800U upper limb Concomitant treatment BoNTA indication spasticity Any elbow flexor contracture prohibit MAS evaluation and/or elbow flexion improvement least 1 step MAS Cutaneous joint inflammation affect upper limb Is likely start spasticity treatment study Is likely start physiotherapy treatment study Other ongoing neurological disorder ( e.g. , myasthenia gravis ) History dysphagia aspiration Use agent interfere neuromuscular transmission ( e.g. , aminoglycosides ) Treated investigational medicinal product within 30 day start study Known sensitivity BoNTA component Dysport , Is risk pregnancy lactate . Females childbearing potential must provide negative pregnancy test ( UhCG ) visit 1 must use adequate contraception . Non childbearing potential define postmenopause least one year , surgical sterilisation hysterectomy least three month start study , Has history , know current , problem alcohol drug abuse , Has mental condition render subject unable understand nature , scope possible consequence study , and/or evidence uncooperative attitude , Has abnormal baseline finding , medical condition ( ) laboratory finding , opinion investigator , might jeopardise subject 's safety decrease chance obtain satisfactory data need achieve objective ( ) study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>